These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16141339)

  • 1. Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells.
    Zou GM; Chen JJ; Yoder MC; Wu W; Rowley JD
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13236-41. PubMed ID: 16141339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembling a gene regulatory network for specification of the B cell fate.
    Medina KL; Pongubala JM; Reddy KL; Lancki DW; Dekoter R; Kieslinger M; Grosschedl R; Singh H
    Dev Cell; 2004 Oct; 7(4):607-17. PubMed ID: 15469848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In utero exposure to alcohol alters cell fate decisions by hematopoietic progenitors in the bone marrow of offspring mice during neonatal development.
    Wang H; Zhou H; Moscatello KM; Dixon C; Brunson LE; Chervenak R; Chervenak DC; Zhao X; Wolcott RM
    Cell Immunol; 2006 Jan; 239(1):75-85. PubMed ID: 16797505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2A Antagonizes PU.1 Activity through Inhibition of DNA Binding.
    Rogers JH; Owens KS; Kurkewich J; Klopfenstein N; Iyer SR; Simon MC; Dahl R
    Biomed Res Int; 2016; 2016():3983686. PubMed ID: 26942192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages.
    Arinobu Y; Mizuno S; Chong Y; Shigematsu H; Iino T; Iwasaki H; Graf T; Mayfield R; Chan S; Kastner P; Akashi K
    Cell Stem Cell; 2007 Oct; 1(4):416-27. PubMed ID: 18371378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient progenitor B cell lines.
    Schweitzer BL; DeKoter RP
    J Immunol; 2004 Jan; 172(1):144-54. PubMed ID: 14688320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human embryonic stem cell-derived CD34+ cells: efficient production in the coculture with OP9 stromal cells and analysis of lymphohematopoietic potential.
    Vodyanik MA; Bork JA; Thomson JA; Slukvin II
    Blood; 2005 Jan; 105(2):617-26. PubMed ID: 15374881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of B lymphocyte and macrophage development by graded expression of PU.1.
    DeKoter RP; Singh H
    Science; 2000 May; 288(5470):1439-41. PubMed ID: 10827957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion of B cell commitment upon loss of Pax5 expression.
    Mikkola I; Heavey B; Horcher M; Busslinger M
    Science; 2002 Jul; 297(5578):110-3. PubMed ID: 12098702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors.
    Scott EW; Fisher RC; Olson MC; Kehrli EW; Simon MC; Singh H
    Immunity; 1997 Apr; 6(4):437-47. PubMed ID: 9133423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5.
    Nutt SL; Heavey B; Rolink AG; Busslinger M
    Nature; 1999 Oct; 401(6753):556-62. PubMed ID: 10524622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Context-dependent Pax-5 repression of a PU.1/NF-kappaB regulated reporter gene in B lineage cells.
    Linderson Y; French NS; Neurath MF; Pettersson S
    Gene; 2001 Jan; 262(1-2):107-14. PubMed ID: 11179673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enforced expression of PU.1 rescues osteoclastogenesis from embryonic stem cells lacking Tal-1.
    Tsuneto M; Tominaga A; Yamazaki H; Yoshino M; Orkin SH; Hayashi S
    Stem Cells; 2005; 23(1):134-43. PubMed ID: 15625130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hematopoietic cell-specific transcription factor PU.1 is critical for expression of CD11c.
    Yashiro T; Kasakura K; Oda Y; Kitamura N; Inoue A; Nakamura S; Yokoyama H; Fukuyama K; Hara M; Ogawa H; Okumura K; Nishiyama M; Nishiyama C
    Int Immunol; 2017 Feb; 29(2):87-94. PubMed ID: 28338898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation.
    Dahl R; Simon MC
    Blood Cells Mol Dis; 2003; 31(2):229-33. PubMed ID: 12972030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of an active tissue-specific chromatin domain initiated by epigenetic marking at the embryonic stem cell stage.
    Szutorisz H; Canzonetta C; Georgiou A; Chow CM; Tora L; Dillon N
    Mol Cell Biol; 2005 Mar; 25(5):1804-20. PubMed ID: 15713636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visualizing PU.1 activity during hematopoiesis.
    Back J; Allman D; Chan S; Kastner P
    Exp Hematol; 2005 Apr; 33(4):395-402. PubMed ID: 15781329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PU.1 protein expression has a positive linear association with protein expression of germinal centre B cell genes including BCL-6, CD10, CD20 and CD22: identification of PU.1 putative binding sites in the BCL-6 promotor.
    Torlakovic E; Malecka A; Myklebust JH; Tierens A; Aasheim HC; Nesland JM; Smeland E; Kvaløy S; Delabie J
    J Pathol; 2005 Jul; 206(3):312-9. PubMed ID: 15892171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell fate specification: role of master regulatory switch transcription factor PU.1 in differential hematopoiesis.
    Gangenahalli GU; Gupta P; Saluja D; Verma YK; Kishore V; Chandra R; Sharma RK; Ravindranath T
    Stem Cells Dev; 2005 Apr; 14(2):140-52. PubMed ID: 15910240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.